01—Abstract
Summary
Summary of the 8-K filed September 11, 2025. Cited figures are marked; the original filing is the authoritative source.
This Form 8-K is an administrative filing with no financial results, earnings, balance sheet data, or management commentary.
Its substance is Item 9.01 (Financial Statements and Exhibits), which lists three exhibits: a legal opinion of Karen Wang, Esq. (Exhibit 5.01), a schedule of Citigroup Inc. securities registered under Section 12(b) of the Exchange Act as of the filing date (Exhibit 99.01), and the Inline XBRL cover page (Exhibit 104). The filing appears to document the current listing status of Citigroup's registered securities rather than report any material event.
Exhibit 99.01 lists the common stock (ticker C) on the New York Stock Exchange, along with several registered securities: 7.625%a Trust Preferred Securities of Citigroup Capital III (C/36Y), 7.875% Fixed/Floating Rate Trust Preferred Securities of Citigroup Capital XIII (C N), and multiple Series N floating rate medium-term notes issued by Citigroup Global Markets Holdings Inc. (CGMHI) maturing between 2026 and 2029, each guaranteed by Citigroup Inc. The excerpt provided ends partway through this list, so it may not show every registered security. For investors, the filing carries little informational value on its own.
It does not indicate new debt issuance, dividend changes, earnings, or other material developments. Its main relevance is confirming the exchange listings and identifiers of Citigroup's publicly traded equity and debt instruments, including the CGMHI notes with 2026 maturities that may approach redemption or repayment.
02—Key points
Key Highlights
- Administrative 8-K filed September 11, 2025, with no reported financial results, earnings, or material business events.
- Item 9.01 lists three exhibits: a legal opinion (Exhibit 5.01), a schedule of registered securities (Exhibit 99.01), and the Inline XBRL cover page (Exhibit 104).
- Common stock trades on the New York Stock Exchange under ticker C.
- Registered trust preferred securities include the 7.625% TruPS of Citigroup Capital III (C/36Y) and the 7.875% fixed/floating rate TruPS of Citigroup Capital XIII (C N), both NYSE-listed.
- Multiple Series N floating rate medium-term notes issued by CGMHI, with Citigroup's guarantee, are registered on the NYSE with maturities from September 2026 to March 2029.
- The securities list in the excerpt appears truncated, so additional registered instruments may exist beyond those shown.
- The filing does not disclose new issuances, dividend actions, or changes to Citigroup's capital position.
03—Questions
Frequently Asked Questions
Does this 8-K report Citigroup's financial results or any material event?
No. The filing contains no financial results, earnings figures, or disclosure of a material event. It is an Item 9.01 exhibit filing that lists registered securities and attaches a legal opinion and XBRL cover page.
What is the purpose of Exhibit 5.01?
Exhibit 5.01 is a legal opinion from Karen Wang, Esq., typically provided in connection with the registration or issuance of securities. The excerpt does not state which offering it relates to, so the specific transaction cannot be confirmed from this document alone.
Which securities are registered and where do they trade?
Citigroup's common stock (C) and several debt and trust preferred instruments are registered on the New York Stock Exchange. These include the Citigroup Capital III and Capital XIII trust preferreds and CGMHI Series N floating rate notes, each guaranteed by Citigroup Inc.
Should investors take any action based on this filing?
The filing does not call for investor action. Holders of the listed securities may want to note the maturity dates of the CGMHI notes, particularly those due in 2026, and consult the offering documents and the company's periodic reports for terms and any changes in status.
04—Continue